Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DASSONNEVILLE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DASSONNEVILLE is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BAILLEUL (59270), this company of category PME shows in 2024 a net income positive of 154 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELARL PHARMACIE DASSONNEVILLE (SIREN 531134989)
Kennzahl 2024 2023 2022 2021 2020 2019 2018 2017
Umsatz N/C N/C N/C N/C N/C N/C N/C N/C
Nettoergebnis 154 388 € 71 797 € 146 205 € 123 003 € 81 403 € 44 113 € 17 981 € 74 682 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Nettomarge N/C N/C N/C N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2024, SELARL PHARMACIE DASSONNEVILLE generates positive net income of 154 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 75 k€ -> 154 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

154 388 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 125%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

125.383%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

37.262%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

27.0%

Entwicklung der Solvenzkennzahlen
SELARL PHARMACIE DASSONNEVILLE

Positionnement sectoriel

Debt ratio
125.38 2024
2022
2023
2024
Q1: 16.46
Méd: 58.47
Q3: 154.89
Average -8 pts über 3 Jahre

In 2024, the debt ratio of SELARL PHARMACIE DASSONNE... (125.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
37.26% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Average +10 pts über 3 Jahre

In 2024, the financial autonomy of SELARL PHARMACIE DASSONNE... (37.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 242.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

242.045

Entwicklung der Liquiditätskennzahlen
SELARL PHARMACIE DASSONNEVILLE

Positionnement sectoriel

Liquidity ratio
242.04 2024
2022
2023
2024
Q1: 129.47
Méd: 182.13
Q3: 260.78
Good +15 pts über 3 Jahre

In 2024, the liquidity ratio of SELARL PHARMACIE DASSONNE... (242.04) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positionnement de SELARL PHARMACIE DASSONNEVILLE dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DASSONNEVILLE is estimated at 2 155 370 € (range 1 500 966€ - 3 224 557€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1500k€ 2155k€ 3224k€
2 155 370 € Range: 1 500 966€ - 3 224 557€
NAF 5 année 2024

Valuation method used

Net Income Multiple
154 388 € × 14.0x = 2 155 371 €
Range: 1 500 966€ - 3 224 558€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DASSONNEVILLE with other companies in the same sector:

Frequently asked questions about SELARL PHARMACIE DASSONNEVILLE

What is the revenue of SELARL PHARMACIE DASSONNEVILLE ?

The revenue of SELARL PHARMACIE DASSONNEVILLE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DASSONNEVILLE profitable?

Yes, SELARL PHARMACIE DASSONNEVILLE generated a net profit of 154 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DASSONNEVILLE ?

The headquarters of SELARL PHARMACIE DASSONNEVILLE is located in BAILLEUL (59270), in the department Nord.

Where to find the tax return of SELARL PHARMACIE DASSONNEVILLE ?

The tax return of SELARL PHARMACIE DASSONNEVILLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DASSONNEVILLE operate?

SELARL PHARMACIE DASSONNEVILLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.